Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04129164 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

A Phase 2 study of Sjögren's Syndrome, sponsored by Amgen.

Completed
Registry status
Phase 2
Development phase
183
Enrollment target
20
Study locations

NCT04129164 is a Phase 2 study of Sjögren's Syndrome that has completed, run by Amgen. The registered enrollment target is 183 participants, below the 463-participant average among 4 other Sjögren's Syndrome trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04129164, a Phase 2 study of Sjögren's Syndrome, has completed, sponsored by Amgen.

COMPLETED
Registry status
Phase 2
Development phase
183 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the study is to evaluate the efficacy, safety, and tolerability of VIB4920 (formerly MEDI4920) in adult participants with Sjögren's Syndrome (SS).

Conditions Studied

Sjögren's Syndrome

Interventions

  • DRUG Placebo
  • DRUG VIB4920

Study Locations (20)

North Carolina

  • Research Site - Charlotte
  • Research Site - Durham
  • Research Site - Salisbury
  • Research Site - Wilmington

Texas

  • Research site - Dallas
  • Research Site - Houston
  • Research Site - Houston

Other

  • Research Site - Bordeaux
  • Research Site - Brest
  • Research Site - Grenoble

California

  • Research Site - Fullerton
  • Research site - Upland

Maryland

  • Research Site - Baltimore
  • Research Site - Wheaton

Georgia

  • Research Site - Lawrenceville

Kansas

  • Research Site - Kansas City

Massachusetts

  • Research Site - Boston

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2019-12-09
Est. Completion 2023-03-10
Phase Phase 2

Sponsor

Amgen

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04129164

The ClinicalTrials.gov registry entry for NCT04129164 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 463-participant average among 4 other Sjögren's Syndrome trials with a reported enrollment target (60% lower). The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sjögren's Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04129164 reports 20 study locations spanning 11 distinct geographic areas - top geographies include North Carolina, Texas, Other.

Frequently Asked Questions

What is clinical trial NCT04129164 about?

NCT04129164 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome". The purpose of the study is to evaluate the efficacy, safety, and tolerability of VIB4920 (formerly MEDI4920) in adult participants with Sjögren's Syndrome (SS).

What is the current status of trial NCT04129164?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 183 participants. The study started on 2019-12-09. Estimated completion is 2023-03-10.

What conditions does trial NCT04129164 study?

This clinical trial studies the following conditions: Sjögren's Syndrome.

What interventions are being tested in trial NCT04129164?

The interventions under investigation include: Placebo (DRUG), VIB4920 (DRUG).

Who is sponsoring clinical trial NCT04129164?

This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04129164 being conducted?

This trial has 20 study locations across California, Georgia, Kansas, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sjögren's Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sjögren's Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.